Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONY-P1 Vaccine in Stage D0 Prostate Cancer
NCT00514072Phase 2Unknown
- Sponsor
- GemVax & KAEL Co., Ltd.
- Start
- Mar 2007
- Primary completion
- Sep 2012
- Countries
- 1
01
Overview
A Phase 2 trial of Prostate cancer vaccine ONY-P1 in prostate cancer (PCa), sponsored by GemVax & KAEL Co., Ltd.. Status: unknown.
02
Drugs
Prostate cancer vaccine ONY-P1
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00514072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00514072.